Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women

American Journal of Clinical Nutrition

Volumn 93, Issue 4, 2011, Pages 719-726

  Wildman, Rachel P ^a   Janssen, Imke ^b   Khan, Unab I ^c   Thurston, Rebecca ^d,e   Barinas Mitchell, Emma ^e   El Khoudary, Samar R ^e   Everson Rose, Susan A ^f   Kazlauskaite, Rasa ^b   Matthews, Karen A ^d,e   Sutton Tyrrell, Kim ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MIDDLE AGED; RACE DIFFERENCE; RISK FACTOR; SUBCUTANEOUS FAT;

AFRICAN AMERICANS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CAROTID ARTERIES; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; TUNICA INTIMA;

EID: 79953230074     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.007153     Document Type: Article

References (30)

1. Narumi H, Yoshida K, Hashimoto N, et al. Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening. Int J Cardiol 2009;135:150-5.
2. Yim JE, Heshka S, Albu JB, Heymsfield S, Gallagher D. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol 2008;104:700-7. (Pubitemid 351468798)
3. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 2005;90:4573-8. (Pubitemid 41159345)
4. Meininger G, Hadigan C, Rietschel P, Grinspoon S. Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men. Am J Clin Nutr 2002;76:460-5. (Pubitemid 34804073)
5. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004;89:2632-9. (Pubitemid 38766342)
6. Snijder MB, Visser M, Dekker JM, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-8. (Pubitemid 40543303)
7. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, Treuth MS. Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr 1997;65:855-60. (Pubitemid 27111096)
8. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
9. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009;32:1068-75.
10. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-8.
11. Vega GL, Adams-Huet B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006;91:4459-66. (Pubitemid 44833423)
12. Demerath EW, Reed D, Rogers N, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 2008;88:1263-71.
13. Pou KM, Massaro JM, Hoffmann U, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009;32:481-5.
14. Carroll JF, Chiapa AL, Rodriquez M, et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity (Silver Spring) 2008;16:600-7. (Pubitemid 351337456)
15. Kanaley JA, Giannopoulou I, Tillapaugh-Fay G, Nappi JS, Ploutz-Snyder LL. Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism 2003; 52:186-91. (Pubitemid 36388841)
16. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995;61:765-71.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9. (Pubitemid 34251969)
18. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 2000;49:1042-8. (Pubitemid 30349428)
19. Sowers MF, Crawford S, Sternfeld B, et al. Design, survey sampling and recruitment methods of SWAN: a multi-cetner, multi-ethnic community-based cohort study of women and the menopausal transition. In: Lobos R, Marcus R, Kelsey JL, eds. Menopause: biology and pathobiology. San Diego, CA: Academic Press, 2000:175-88.
20. Jensen MD. Lipolysis: contribution from regional fat. Annu Rev Nutr 1997;17:127-39. (Pubitemid 27328795)
21. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-82. (Pubitemid 38535056)
22. Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90:2282-9. (Pubitemid 40586275)
23. Fisher FM, McTernan PG, Valsamakis G, et al. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res 2002;34:650-4. (Pubitemid 36398701)
24. Hegele RA. Premature atherosclerosis associated with monogenic insulin resistance. Circulation 2001;103:2225-9. (Pubitemid 32433709)
25. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.
26. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005;54:3140-7. (Pubitemid 43334367)
27. Volzke H, Robinson DM, Kleine V, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005;11:1848-53. (Pubitemid 40520783)
28. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005;25:1045-50. (Pubitemid 40627853)
29. Lovejoy JC, Smith SR, Rood JC. Comparison of regional fat distribution and health risk factors in middle-aged white and African American women: the Healthy Transitions Study. Obes Res 2001;9:10-6. (Pubitemid 33603825)
30. Goedecke JH, Levitt NS, Lambert EV, et al. Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women. Obesity (Silver Spring) 2009;17:1506-12.